Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.
Article
Google Scholar
Weernink MGM, Groothuis-Oudshoorn CGM, IJzerman MJ, van Til JA. Valuing treatments for Parkinson disease incorporating process utility: performance of best-worst scaling, time trade-off, and visual analogue scales. Value Health. 2016;19(2):226–32.
Article
PubMed
Google Scholar
Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
Article
CAS
PubMed
Google Scholar
McDonough CM, Tosteson AN. Measuring preferences for cost-utility analysis: how choice of method may influence decision-making. Pharmacoeconomics. 2007;25(2):93–106.
Article
PubMed
PubMed Central
Google Scholar
Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health. 2012;15(3):475–84.
Article
PubMed
Google Scholar
Haring R, Feng YS, Moock J, Volzke H, Dorr M, Nauck M, Wallaschofski H, Kohlmann T. Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does best. BMC Med Res Methodol. 2011;11:103.
Article
PubMed
PubMed Central
Google Scholar
Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, et al. A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ. 2003;4(3):222–31.
Article
PubMed
Google Scholar
Crockett AJ, Cranston JM, Moss JR, Alpers JH. The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham health profile. Qual Life Res. 1996;5(3):330–8.
Article
CAS
PubMed
Google Scholar
Xia P, Li N, Hau KT, Liu C, Lu Y. Quality of life of Chinese urban community residents: a psychometric study of the mainland Chinese version of the WHOQOL-BREF. BMC Med Res Methodol. 2012;12:37.
Article
PubMed
PubMed Central
Google Scholar
Mo F, Choi BC, Li FC, Merrick J. Using health utility index (HUI) for measuring the impact on health-related quality of life (HRQL) among individuals with chronic diseases. ScientificWorldJournal. 2004;4:746–57.
Article
PubMed
PubMed Central
Google Scholar
Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res. 1982;30(6):1043–69.
Article
CAS
PubMed
Google Scholar
Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med. 2001;33(5):358–70.
Article
CAS
PubMed
Google Scholar
Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006;9(4):213–8.
Article
PubMed
Google Scholar
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–43.
Article
CAS
PubMed
Google Scholar
Lee YJ, Lee S, Song S, Lee S, Suh D. Health utility in Myelofibrosis patients and comparison between health utility values measured by time trade off and visual analogue scale. Value Health. 2017;20(5):A115–6.
Google Scholar
O'Boyle CJ, Royston CM, Sedman PC. Cost-utility analysis of open versus laparoscopic groin hernia repair: results from a multicentre randomized clinical trial (Br J Surg 2001; 88: 653-61). Br J Surg. 2001;88(11):1543–5.
Article
CAS
PubMed
Google Scholar
Sun S, Chen J, Johannesson M, Kind P, Xu L, Zhang Y, Burstrom K. Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey. Qual Life Res. 2008;20(3):309–20.
Article
Google Scholar
Tan Z, Liang Y, Liu S, Cao W, Tu H, Guo L, Xu Y. Health-related quality of life as measured with EQ-5D among populations with and without specific chronic conditions: a population-based survey in Shaanxi Province China. PloS one. 2013;8(7):e65958.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien BJ. Are health states “timeless”? The case of the standard gamble method. J Clin Epidemiol. 1999;52(11):1047–53.
Article
CAS
PubMed
Google Scholar
Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum E. Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med Decis Making. 2014;34(1):8–20.
Article
PubMed
Google Scholar
Szende AG, Oppe M, Devlin NJ. EQ-5d value sets: inventory, comparative review and user guide; 2007. p. 1–102.
Book
Google Scholar
Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA, Zethraeus N. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–42.
Article
PubMed
Google Scholar
Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res. 1998;29(3):201–9.
Article
CAS
PubMed
Google Scholar
Craig BM. The duration effect: a link between TTO and VAS values. Health Econ. 2009;18(2):217–25.
Article
PubMed
PubMed Central
Google Scholar
Cooper A, Wallman JK, Gulfe A. What PASSes for good? Experience-based Swedish and hypothetical British EuroQol 5-dimensions preference sets yield markedly different point estimates and patient acceptable symptom state cut-off values in chronic arthritis patients on TNF blockade. Scand J Rheumatol. 2016;45(6):470–3.
Article
CAS
PubMed
Google Scholar
Zrubka Z, Beretzky Z, Hermann Z, Brodszky V, Gulacsi L, Rencz F, Baji P, Golicki D, Prevolnik-Rupel V, Pentek M. A comparison of European, polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases. Eur J Health Econ. 2019;20(Suppl 1):119–32.
Article
PubMed
PubMed Central
Google Scholar
Mendeloff J. Measuring elusive benefits: on the value of health. J Health Polit Policy Law. 1983;8(3):554–80.
Article
CAS
PubMed
Google Scholar
De Wit GA, Busschbach JJ, De Charro FT. Sensitivity and perspective in the valuation of health status: whose values count? Health Econ. 2000;9(2):109–26.
Article
PubMed
Google Scholar
Craig BM, Busschbach JJ, Salomon JA. Keep it simple: ranking health states yields values similar to cardinal measurement approaches. J Clin Epidemiol. 2009;62(3):296–305.
Article
PubMed
Google Scholar
Craig BM, Busschbach JJ, Salomon JA. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods. Med Care. 2009;47(6):634–41.
Article
PubMed
PubMed Central
Google Scholar
Green C, Brazier J, Deverill M. Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics. 2000;17(2):151–65.
Article
CAS
PubMed
Google Scholar
Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care. 2007;45(3):238–44.
Article
PubMed
Google Scholar
Mortimer D, Segal L. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making. 2008;28(1):66–89.
Article
PubMed
Google Scholar
Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013;14(1):57–66.
Article
PubMed
Google Scholar
Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.
Article
CAS
PubMed
Google Scholar
Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108.
Article
CAS
PubMed
Google Scholar
Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni JM, Luo N. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34(10):993–1004.
Article
PubMed
PubMed Central
Google Scholar
Bailey H, Kind P, La Foucade A. Results from an exploratory study to test the performance of EQ-5D-3L valuation subsets based on orthogonal designs, and an investigation into some modeling and transformation alternatives for the utility function. Heal Econ Rev. 2014;4(1):29.
Article
Google Scholar
Yang Z, Luo N, Bonsel G, Busschbach J, Stolk E. Effect of health state sampling methods on model predictions of EQ-5D-5L values: small designs can suffice. Value Health. 2019;22(1):38–44.
Article
PubMed
Google Scholar
Murre JM, Dros J. Replication and analysis of Ebbinghaus' forgetting curve. PLoS One. 2015;10(7):e0120644.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604.
Article
PubMed
Google Scholar
Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17(4):445–53.
Article
PubMed
Google Scholar
Zhuo L, Xu L, Ye J, Sun S, Zhang Y, Burstrom K, Chen J. Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value Health. 2018;21(11):1330–7.
Article
PubMed
Google Scholar
Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS. Time trade-off and attitudes toward euthanasia: implications of using ‘death’ as an anchor in health state valuation. Qual Life Res. 2013;22(4):705–14.
Article
PubMed
Google Scholar
Lee BS, Kymes SM, Nease RF Jr, Sumner W, Siegfried CJ, Gordon MO. The impact of anchor point on utilities for 5 common ophthalmic diseases. Ophthalmology. 2008;115(5):898–903 e894.
Article
PubMed
Google Scholar
Lee JY, Lee E. Assessment of utility for heart failure using visual analogue scale (vas), time-trade off (Tto) and Euroqol-5 dimension (Eq-5d) in the Korean general population. Value Health. 2016;19(7):A868–9.
Article
Google Scholar
Stiggelbout AM, Eijkemans MJC, Kiebert GM, Kievit J, Leer JWH, DeHaes HJCJM. The 'utility' of the visual analog scale in medical decision making and technology assessment - is it an alternative to the time trade-off? Int J Technol Assess Health Care. 1996;12(2):291–8.
Article
CAS
PubMed
Google Scholar
Emilsson L, Lindahl B, Koster M, Lambe M, Ludvigsson JF. Review of 103 Swedish healthcare quality registries. J Intern Med. 2014.
Jin X, Liu GG, Luo N, Li H, Guan H, Xie F. Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Qual Life Res. 2016;25(4):979–86.
Article
PubMed
Google Scholar
Yin Z, Li J, Ma K, Ning X, Chen H, Fu H, Zhang H, Wang C, Bruera E, Hui D. Development of palliative Care in China: a tale of three cities. Oncologist. 2017;22(11):1362–7.
Article
PubMed
PubMed Central
Google Scholar
Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ. 2010;19(6):683–96.
PubMed
Google Scholar
Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O. Valuation and modeling of EQ-5D-5L health states using a hybrid approach. Med Care. 2014;55:e51–8.
Article
Google Scholar
Scalone L, Cortesi PA, Ciampichini R, Belisari A, D'Angiolella LS, Cesana G, Mantovani LG. Italian population-based values of EQ-5D health states. Value Health. 2013;16(5):814–22.
Article
PubMed
Google Scholar
Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health. 2009;37(5):459–66.
Article
PubMed
Google Scholar
Andrade MV, Noronha K, Kind P, Reis Cde B, de Carvalho LR. Logical inconsistencies in 3 preference elicitation methods for EQ-5D health states: a study in the Brazilian population. Med Decis Making. 2016;36(2):242–52.
Article
PubMed
Google Scholar
Sun S, Chen J, Kind P, Xu L, Zhang Y, Burstrom K. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China. Qual Life Res. 2015;24(3):693–703.
Article
PubMed
Google Scholar
Badia X, Monserrat S, Roset M, Herdman M. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res. 1999;8(4):303–10.
Article
CAS
PubMed
Google Scholar